Launch of Greenflint – the original resource

May 2006 marks the arrival of Greenflint – Rx Communications’ sister company – to be officially launched during ISPOR’s 11th Annual International meeting at the Marriott in Philadelphia, USA , from 20–24 May 2006. At Greenflint we understand the increasing significance of health economics and outcomes research in drug development and marketing, and in healthcare…

Details

Getting drugs accepted: who succeeds and why

By Robert Hand Health economics data play an increasingly important role in getting pharmaceuticals accepted for the drug formularies established by health insurance plans and regulatory authorities. A drug manufacturer needs to know how to use health economics data to gain acceptance for its drugs. One way is to gather case studies to show which…

Details

Getting the word out without giving away trade secrets

By Robert Hand In the United States, there has been growing acceptance of the Academy of Managed Care Pharmacy (AMCP) Drug Dossier format for submitting consistent, evidence-based information about drugs. And Australia, Great Britain, Germany, and other countries have national systems to provide clinicians with comparable information about new drugs. But drug makers fear that…

Details